Berlin – While working at SMP, members of the YPOG team advised medical cannabis producer and wholesaler DEMECAN on its new financing round. New investors as well as several existing shareholders participated in the investment in the upper single-digit million range. DEMECAN already relied on the expertise of the law firm in previous financing rounds and was again comprehensively legally advised by a Team led by Martin Schaper. The financing will be used for further growth and the expansion of the production facility near Dresden into Europe's most modern facility for the cultivation and further processing of medicinal cannabis.
"DEMECAN operates as the only independent German production and trading company for medical cannabis in a growing market. We are pleased to be part of the developments," said Martin Schaper.
Further information can be found in German on the company website.
Team:
Dr. Martin Schaper (Lead), Partner
Dr. Martyna Sabat, Associate
About us
YPOG is a law firm specialized in tax and business law, active in the core fields of Funds, Tax, Banking + Finance, and Transactions. The team at YPOG represents a broad client base, which ranges from emerging technology companies and family-run SMEs to large corporations, as well as private equity, and venture capital funds. YPOG is one of the leading advisors for venture capital, private equity, and fund structuring in Germany. The firm and its partners have been recognized nationally and internationally by JUVE, Best Lawyers, Legal 500, Focus, Chambers and Partners as well as Leaders League. Today, YPOG has more than 150 experienced attorneys, tax advisors and tax specialists and a notary, in four offices, located in Berlin, Hamburg, Cologne, and Munich.
